Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
3.250
+0.030 (0.93%)
Apr 29, 2026, 3:04 PM CST
15.66% (1Y)
| Market Cap | 4.82B |
| Revenue (ttm) | 7.25B |
| Net Income (ttm) | 14.35M |
| Shares Out | 1.48B |
| EPS (ttm) | 0.01 |
| PE Ratio | 336.05 |
| Forward PE | n/a |
| Dividend | 0.00 (0.06%) |
| Ex-Dividend Date | n/a |
| Volume | 45,481,267 |
| Average Volume | 127,491,202 |
| Open | 3.210 |
| Previous Close | 3.220 |
| Day's Range | 3.160 - 3.260 |
| 52-Week Range | 2.770 - 4.690 |
| Beta | 0.37 |
| RSI | 47.46 |
| Earnings Date | Apr 23, 2026 |